Signaturefd, LLC Erasca, Inc. Transaction History

Signaturefd, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$1.67 - $2.55 $1,865 - $2,848	-1,117 Reduced 41.87%	1,551 $3,000
Q4 2023 Jan 31, 2024	SELL	$1.67 - $2.49 $4,348 - $6,483	-2,604 Reduced 49.39%	2,668 $5,000
Q3 2023 Nov 03, 2023	BUY	$1.97 - $2.91 $5,297 - $7,824	2,689 Added 104.1%	5,272 $10,000
Q2 2023 Aug 01, 2023	SELL	$2.57 - $3.3 $2,233 - $2,867	-869 Reduced 25.17%	2,583 $7,000
Q1 2023 Apr 28, 2023	BUY	$2.74 - $4.44 $9,074 - $14,705	3,312 Added 2365.71%	3,452 $10,000
Q4 2022 Jan 27, 2023	BUY	$3.89 - $8.57 $544 - $1,199	140 New	140 $0

140

229M

28.7K

117K

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $289M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.